Clinical and genetic correlates of islet-autoimmune signatures in juvenile-onset type 1 diabetes

被引:26
|
作者
Claessens, Laura A. [1 ]
Wesselius, Joris [1 ]
van Lummel, Menno [1 ]
Laban, Sandra [1 ]
Mulder, Flip [2 ]
Mul, Dick [3 ]
Nikolic, Tanja [1 ]
Aanstoot, Henk-Jan [3 ]
Koeleman, Bobby P. C. [2 ]
Roep, Bart O. [1 ,4 ]
机构
[1] Leiden Univ, Med Ctr, Dept Immunohaematol & Blood Transfus, Leiden, Netherlands
[2] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands
[3] Diabeter, Ctr Pediat & Adolescent Diabet Care & Res, Rotterdam, Netherlands
[4] City Hope Natl Med Ctr, Dept Diabet Immunol, Diabet & Metab Res Inst, Beckman Res Inst,Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
关键词
Autoimmune disease; Autoreactive T cells; Disease endotypes; Disease heterogeneity; Epitope spreading; Immunotherapy; Islet autoantigen; Patient heterogeneity; Personalised medicine; Precision medicine; GENOME-WIDE ASSOCIATION; RISK SCORE; SUSCEPTIBILITY; CELL; DISEASE; AUTOANTIBODIES; METAANALYSIS; PREDICTION; CHILDREN; LOCI;
D O I
10.1007/s00125-019-05032-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis Heterogeneity in individuals with type 1 diabetes has become more generally appreciated, but has not yet been extensively and systematically characterised. Here, we aimed to characterise type 1 diabetes heterogeneity by creating immunological, genetic and clinical profiles for individuals with juvenile-onset type 1 diabetes in a cross-sectional study. Methods Participants were HLA-genotyped to determine HLA-DR-DQ risk, and SNP-genotyped to generate a non-HLA genetic risk score (GRS) based on 93 type 1 diabetes-associated SNP variants outside the MHC region. Islet autoimmunity was assessed as T cell proliferation upon stimulation with the beta cell antigens GAD65, islet antigen-2 (IA-2), preproinsulin (PPI) and defective ribosomal product of the insulin gene (INS-DRIP). Clinical parameters were collected retrospectively. Results Of 80 individuals, 67 had proliferation responses to one or more islet antigens, with vast differences in the extent of proliferation. Based on the multitude and amplitude of the proliferation responses, individuals were clustered into non-, intermediate and high responders. High responders could not be characterised entirely by enrichment for the highest risk HLA-DR3-DQ2/DR4-DQ8 genotype. However, high responders did have a significantly higher non-HLA GRS. Clinically, high T cell responses to beta cell antigens did not reflect in worsened glycaemic control, increased complications, development of associated autoimmunity or younger age at disease onset. The number of beta cell antigens that an individual responded to increased with disease duration, pointing to chronic islet autoimmunity and epitope spreading. Conclusions/interpretation Collectively, these data provide new insights into type 1 diabetes disease heterogeneity and highlight the importance of stratifying patients on the basis of their genetic and autoimmune signatures for immunotherapy and personalised disease management.
引用
收藏
页码:351 / 361
页数:11
相关论文
共 50 条
  • [1] Clinical and genetic correlates of islet-autoimmune signatures in juvenile-onset type 1 diabetes
    Laura A. Claessens
    Joris Wesselius
    Menno van Lummel
    Sandra Laban
    Flip Mulder
    Dick Mul
    Tanja Nikolic
    Henk-Jan Aanstoot
    Bobby P. C. Koeleman
    Bart O. Roep
    Diabetologia, 2020, 63 : 351 - 361
  • [2] Prevalence of islet autoantibodies in Thai juvenile-onset type 1 diabetes
    Trisorus, Chayanis
    Aroonparkmongkol, Suphab
    Kongmanas, Hataichanok Bansiddhi
    Sahakitrungruang, Taninee
    PEDIATRICS INTERNATIONAL, 2018, 60 (11) : 1002 - 1007
  • [3] Novel genetic risk factors influence progression of islet autoimmunity to type 1 diabetes
    Onengut-Gumuscu, Suna
    Paila, Umadevi
    Chen, Wei-Min
    Ratan, Aakrosh
    Zhu, Zhennan
    Steck, Andrea K.
    Frohnert, Brigitte I.
    Waugh, Kathleen C.
    Webb-Robertson, Bobbie-Jo M.
    Norris, Jill M.
    Lange, Leslie A.
    Rewers, Marian J.
    Rich, Stephen S.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [4] Islet Autoantibody Level Distribution in Type 1 Diabetes and Their Association With Genetic and Clinical Characteristics
    Grace, Sian Louise
    Bowden, Jack
    Walkey, Helen C.
    Kaur, Akaal
    Misra, Shivani
    Shields, Beverley M.
    McKinley, Trevelyan J.
    Oliver, Nick S.
    McDonald, Timothy
    Johnston, Desmond G.
    Jones, Angus G.
    Patel, Kashyap A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (12) : E4341 - E4349
  • [5] Genetic determinants of type 1 diabetes in individuals with weak evidence of islet autoimmunity at disease onset
    Carrera, Paola
    Marzinotto, Ilaria
    Bonfanti, Riccardo
    Massimino, Luca
    Calzavara, Silvia
    Favellato, Mariagrazia
    Jofra, Tatiana
    De Giglio, Valeria
    Bonura, Clara
    Stabilini, Angela
    Favalli, Valeria
    Bondesan, Simone
    Cicalese, Maria Pia
    Laurenzi, Andrea
    Caretto, Amelia
    Frontino, Giulio
    Rigamonti, Andrea
    Molinari, Chiara
    Scavini, Marina
    Sandullo, Federica
    Zapparoli, Ettore
    Caridi, Nicoletta
    Bonfiglio, Silvia
    Castorani, Valeria
    Ungaro, Federica
    Petrelli, Alessandra
    Barera, Graziano
    Aiuti, Alessandro
    Bosi, Emanuele
    Battaglia, Manuela
    Piemonti, Lorenzo
    Lampasona, Vito
    Fousteri, Georgia
    DIABETOLOGIA, 2023, 66 (04) : 695 - 708
  • [6] Integration of Infant Metabolite, Genetic, and Islet Autoimmunity Signatures to Predict Type 1 Diabetes by Age 6 Years
    Webb-Robertson, Bobbie-Jo M.
    Nakayasu, Ernesto S.
    Frohnert, Brigitte, I
    Bramer, Lisa M.
    Akers, Sarah M.
    Norris, Jill M.
    Vehik, Kendra
    Ziegler, Anette G.
    Metz, Thomas O.
    Rich, Stephen S.
    Rewers, Marian J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (08) : 2329 - 2338
  • [7] A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk
    Redondo, Maria J.
    Geyer, Susan
    Steck, Andrea K.
    Sharp, Seth
    Wentworth, John M.
    Weedon, Michael N.
    Antinozzi, Peter
    Sosenko, Jay
    Atkinson, Mark
    Pugliese, Alberto
    Oram, Richard A.
    DIABETES CARE, 2018, 41 (09) : 1887 - 1894
  • [8] The relationship between islet autoantibody status and the genetic risk of type 1 diabetes in adult-onset type 1 diabetes
    Thomas, Nicholas J.
    Walkey, Helen C.
    Kaur, Akaal
    Misra, Shivani
    Oliver, Nick S.
    Colclough, Kevin
    Weedon, Michael N.
    Johnston, Desmond G.
    Hattersley, Andrew T.
    Patel, Kashyap A.
    DIABETOLOGIA, 2023, 66 (02) : 310 - 320
  • [9] Obesity, Islet Cell Autoimmunity, and Cardiovascular Risk Factors in Youth at Onset of Type 1 Autoimmune Diabetes
    Cedillo, Maribel
    Libman, Ingrid M.
    Arena, Vincent C.
    Zhou, Lei
    Trucco, Massimo
    Ize-Ludlow, Diego
    Pietropaolo, Massimo
    Becker, Dorothy J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (01) : E82 - E86
  • [10] Genetic regulatory signatures underlying islet gene expression and type 2 diabetes
    Varshney, Arushi
    Scott, Laura J.
    Welch, Ryan P.
    Erdos, Michael R.
    Chines, Peter S.
    Narisu, Narisu
    Albanus, Ricardo D'O.
    Orchard, Peter
    Wolford, Brooke N.
    Kursawe, Romy
    Vadlamudi, Swarooparani
    Cannon, Maren E.
    Didion, John P.
    Hensley, John
    Kirilusha, Anthony
    Bonnycastle, Lori L.
    Taylor, D. Leland
    Watanabe, Richard
    Mohlke, Karen L.
    Boehnke, Michael
    Collins, Francis S.
    Parker, Stephen C. J.
    Stitzel, Michael L.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (09) : 2301 - 2306